Abstract:The high prevalence of infectious diseases in Africa, combined with weak healthcare systems, poor antimicrobial stewardship, and an unchecked drug supply chain, is steadily reversing the trend in the fight against infectious diseases in this part of the world, posing severe threats to antimicrobial resistance (AMR). AMR continuously evolves and threatens to undermine antimicrobial efficacy and undo advances against infectious diseases. This brewing pandemic is now recognized as a significant worldwide health danger, implicated in several cases of morbidity, mortality, and increasing healthcare costs. Vaccine technology has been proven to be the principal remedy to this imminent danger since it prevents microbial infections. However, since Africa cannot produce its vaccines, it relies on external sources and, as a result, it is significantly affected by vaccine nationalism, hoarding, and instabilities in global supply chains. This has further adversely impacted the ability of African governments to regulate rollouts, protect their citizens, and ultimately rejoin the global economy. This dependency is a severe challenge to Africa's health resilience, as it is unsustainable. Given the inevitability of potential global pandemics and the alarming incidences of multi-drug resistance infections reported daily, Africa must develop the capability to produce its vaccines. The review utilized a systematic search of academic databases and grey literature, as well as a manual search of relevant reports and articles. In this review, we outline the public health threats and concerns that AMR poses to Africans, and the hurdles and advances achieved in vaccine development over the years. We also highlight possible strategies, particularly collaborative efforts, that will accelerate vaccine production and ease the strain of infectious diseases and antimicrobial resistance in Africa. Key findings indicate that Africa has significant gaps in its vaccine manufacturing and distribution capacity, with only a few countries having the ability to produce vaccines. Additionally, existing vaccine production facilities are often outdated and require significant investment to meet international standards. The review also highlights successful initiatives in Africa, such as the mRNA vaccine hub and the African Vaccine Manufacturing Initiative, which have demonstrated the potential for building local vaccine manufacturing capacity. The study concludes that Africa needs to prioritize investment in vaccine research and development, regulatory capacity, and infrastructure to build a sustainable vaccine manufacturing ecosystem. Overall, this review emphasizes the urgent need for Africa to develop its vaccine manufacturing capacity to improve vaccine access and strengthen its ability to respond to future pandemics. The findings underscore the importance of collaboration between African governments, international organizations, and the private sector to build a resilient vaccine ecosystem in Africa.

Regulatory reforms will boost African vaccine production and access

Global regulatory reforms to promote equitable vaccine access in the next pandemic

The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance

Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa

African Medicines Agency: How It Will Change the Landscape of Medicines in Africa

Strengthening Africa’s capacity for vaccine research: Needs and challenges

Local Production of COVID-19 Vaccines: A Strategy for Action

Progress with COVID-19 vaccination in the WHO African Region in 2021

Identifying and costing common gaps in Central and West Africa pharmaceutical regulation

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production

A community engagement framework to accelerate the uptake of malaria vaccines in Africa

Plans to expand African vaccine production face steep hurdles

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems

Advancing Immunization in Africa: Overcoming Challenges to Achieve the 2030 Global Immunization Targets

Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978-2020

Sustainable financing for vaccination towards advancing universal health coverage in the WHO African region: The strategic role of national health insurance

Shielding Africa, Protecting the World: Unleashing the Power of Preventative Use of Ebola Vaccines

An evaluation of infant immunization in Africa: is a transformation in progress?

Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective

A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa

Investing in health R&D: where we are, what limits us, and how to make progress in Africa